Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $1,487 - $1,686
31 Added 0.7%
4,431 $240 Million
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $405 - $453
-7 Reduced 0.16%
4,400 $255 Million
Q1 2023

Apr 04, 2023

BUY
$65.71 - $74.53 $289,583 - $328,453
4,407 New
4,407 $317 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $103B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Authentikos Wealth Advisory, LLC Portfolio

Follow Authentikos Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Authentikos Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Authentikos Wealth Advisory, LLC with notifications on news.